{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T01:06:48Z","timestamp":1791594408587,"version":"4.3.4"},"reference-count":183,"publisher":"SAGE Publications","issue":"12","license":[{"start":{"date-parts":[[1991,12,1]],"date-time":"1991-12-01T00:00:00Z","timestamp":691545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["DICP"],"published-print":{"date-parts":[[1991,12]]},"abstract":"<jats:p>In this report, we review the evolution of bacillus Calmette-Gu\u00e9rin (BCG) immunotherapy as a legitimate form of treatment in superficial, nonmuscle-invasive bladder cancer. In the US, an estimated 45 000 new cases of bladder cancer are diagnosed each year and the annual death rate approaches 11 000. Approximately 70 percent of these cancers are superficial at the time of initial presentation. The treatment of superficial bladder cancer has three objectives: (1) eradication of existing disease, (2) prophylaxis against tumor recurrence, and (3) prevention of tumor progression (either muscular invasion, metastatic spread, or both). Cystectomy generally is reserved for muscle-invasive disease. Transurethral resection of the bladder tumor is the preferred initial therapy. Intravesical instillations of various chemotherapeutic agents following transurethral resection have been extensively investigated. Some of the common agents used include thiotepa, mitomycin, and doxorubicin. Despite such treatment efforts, however, over 40 percent of patients with superficial bladder cancer experience a recurrence of their tumor within three years. Approximately half of these recurrences either present as less-well-differentiated tumors or have already penetrated into the bladder musculature, metastasized, or both. Since Morales et al. first introduced intravesical BCG vaccine for prophylaxis as well as for treatment of superficial bladder tumors in 1976, support has grown rapidly for its use as an alternative to chemotherapy. When used with prophylactic intent following transurethral resection, recurrence rates are lower than those achieved with other agents. In addition, BCG is emerging as the consensus drug of choice for treating carcinoma in situ of the bladder. The mechanisms by which BCG exerts its antitumor activity remain largely unknown. BCG is thought to stimulate a localized, nonspecific inflammatory response that leads to subsequent shedding of tumor cells. A large body of clinical and experimental data suggest an association between the development of an immunologic response to BCG and successful antitumor activity. No universally accepted therapeutic regimen has been agreed upon. One regimen commonly used consists of an ampul of BCG mixed with 50 mL of NaCl 0.9%, instilled once a week for six weeks and retained for two hours prior to voiding. Maintenance therapy generally consists of intravesical doses given at three-month cycles for at least two years of recurrence-free follow-up. Because BCG is a biologic agent, the commercially available products may differ in weight, colony-forming units per vial, and antigenicity. How these product characteristics affect clinical responsiveness to different strains of BCG remains unanswered.<\/jats:p>","DOI":"10.1177\/106002809102501215","type":"journal-article","created":{"date-parts":[[2017,7,1]],"date-time":"2017-07-01T23:44:10Z","timestamp":1498952650000},"page":"1355-1367","source":"Crossref","is-referenced-by-count":13,"title":["BCG and the Treatment of Superficial Bladder Cancer"],"prefix":"10.1177","volume":"25","author":[{"given":"Jeffrey T.","family":"Moss","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dov","family":"Kadmon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[1991,12]]},"reference":[{"key":"e_1_2_1_2_2","first-page":"1081","article-title":"Sur les essais de vaccination antituberculeuse","volume":"103","author":"Cavagnis V","year":"1886","unstructured":"Cavagnis V. Sur les essais de vaccination antituberculeuse. Compt Rend Acad Sci (Paris) 1886; 103: 1081\u20134.","journal-title":"Compt Rend Acad Sci (Paris)"},{"key":"e_1_2_1_3_2","first-page":"97","article-title":"Eye tuberculosis and antitubercular inoculation in the rabbit","volume":"53","author":"Trudeau EL","year":"1893","unstructured":"Trudeau EL. Eye tuberculosis and antitubercular inoculation in the rabbit. N Y State J Med 1893; 53: 97.","journal-title":"N Y State J Med"},{"key":"e_1_2_1_4_2","first-page":"333","article-title":"Tuberculose experimentale sur un mode de traitement et de vaccination","volume":"111","author":"Grancher J","year":"1890","unstructured":"Grancher J, Martin H. Tuberculose experimentale sur un mode de traitement et de vaccination. Compt Rend Acad Sci (Paris) 1890; 111: 333\u20136.","journal-title":"Compt Rend Acad Sci (Paris)"},{"key":"e_1_2_1_5_2","first-page":"48","volume-title":"BCG vaccination against tuberculosis","author":"Guerin C","year":"1957","unstructured":"Guerin C. Early history of BCG. In: Rosenthal SR, ed. BCG vaccination against tuberculosis. Boston: Little, Brown, 1957: 48\u201353."},{"key":"e_1_2_1_6_2","first-page":"371","article-title":"BCG and bacillus vaccines in the prevention of tuberculosis in adolescence and early adult life","volume":"46","author":"Fourth report to medical research council by its tuberculosis vaccine clinical trials committee.","year":"1972","unstructured":"Fourth report to medical research council by its tuberculosis vaccine clinical trials committee. BCG and bacillus vaccines in the prevention of tuberculosis in adolescence and early adult life. Bull World Health Organ 1972; 46: 371\u201385.","journal-title":"Bull World Health Organ"},{"key":"e_1_2_1_7_2","first-page":"119","article-title":"Effet de la stimulation du systeme reticulo-endothelial par l'inoculation du bacille de Calmette-Gu\u00e9rin sur le developpment de l'epithelioma atypique T-8 de Gu\u00e9rin chez le rat","volume":"153","author":"Halpern BN","year":"1959","unstructured":"Halpern BN, Biozzi G, Stiffel C, Effet de la stimulation du systeme reticulo-endothelial par l'inoculation du bacille de Calmette-Gu\u00e9rin sur le developpment de l'epithelioma atypique T-8 de Gu\u00e9rin chez le rat. Compt Rend Soc Biol 1959; 153: 119\u201323.","journal-title":"Compt Rend Soc Biol"},{"key":"e_1_2_1_8_2","doi-asserted-by":"publisher","DOI":"10.1038\/184291a0"},{"key":"e_1_2_1_9_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-6632.1960.tb20026.x"},{"key":"e_1_2_1_10_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF02151865"},{"key":"e_1_2_1_11_2","doi-asserted-by":"publisher","DOI":"10.1038\/190889a0"},{"key":"e_1_2_1_12_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.124.6.1039"},{"key":"e_1_2_1_13_2","first-page":"101","article-title":"Stimulation du systeme reticuloendothelial et developpement des tumeurs malignes experimentales","volume":"156","author":"Halpern BN","year":"1962","unstructured":"Halpern BN, Biozzi G, Stiffel C. Stimulation du systeme reticuloendothelial et developpement des tumeurs malignes experimentales. C R Soc Biol (Paris) 1962; 156: 101\u20135.","journal-title":"C R Soc Biol (Paris)"},{"key":"e_1_2_1_14_2","first-page":"41","article-title":"Relationship between cancer and tuberculosis. I. Effect of tubercle bacilli infection on transplanted tumors in the mouse","volume":"37","author":"Hattori S","year":"1962","unstructured":"Hattori S, Matsuda M. Relationship between cancer and tuberculosis. I. Effect of tubercle bacilli infection on transplanted tumors in the mouse. Kekkaku 1962; 37: 41\u20136.","journal-title":"Kekkaku"},{"key":"e_1_2_1_15_2","first-page":"1034","article-title":"Influence des mycobacterias sur la croissance de tumeurs experimentales greffees. I. Action des injections de B.C.G","volume":"153","author":"Viallier J","year":"1959","unstructured":"Viallier J, Pellet M. Influence des mycobacterias sur la croissance de tumeurs experimentales greffees. I. Action des injections de B.C.G. C R Soc Biol (Paris) 1959; 153: 1034\u20135.","journal-title":"C R Soc Biol (Paris)"},{"key":"e_1_2_1_16_2","first-page":"13","article-title":"Immune status of the primary host toward its own methylcholanthrene-induced sarcomas","volume":"40","author":"Stjernsward J","year":"1968","unstructured":"Stjernsward J. Immune status of the primary host toward its own methylcholanthrene-induced sarcomas. J Natl Cancer Inst 1968; 40: 13\u201322.","journal-title":"J Natl Cancer Inst"},{"key":"e_1_2_1_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(72)92238-6"},{"key":"e_1_2_1_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/0014-2964(71)90039-9"},{"key":"e_1_2_1_19_2","first-page":"240","article-title":"Relation between tumor growth and host resistance","volume":"12","author":"Inooka SI","year":"1965","unstructured":"Inooka SI. Relation between tumor growth and host resistance. Sci Rep Res Inst Tohoku Univ [Med] 1965; 12: 240\u201366.","journal-title":"Sci Rep Res Inst Tohoku Univ [Med]"},{"key":"e_1_2_1_20_2","first-page":"570","article-title":"Tumour growth and non-specific immunity in rats: The mechanisms involved in inhibition of tumor growth","volume":"53","author":"Keller R","year":"1972","unstructured":"Keller R, Hess MW. Tumour growth and non-specific immunity in rats: The mechanisms involved in inhibition of tumor growth. Br J Exp Pathol 1972; 53: 570\u20137.","journal-title":"Br J Exp Pathol"},{"key":"e_1_2_1_21_2","first-page":"1013","article-title":"Stimulating influence of bacillus Calmette-Gu\u00e9rin on immunity to polyoma tumors and spontaneous leukemia","volume":"47","author":"Lemonde P","year":"1971","unstructured":"Lemonde P, Dubreuil R, Guindon A, Stimulating influence of bacillus Calmette-Gu\u00e9rin on immunity to polyoma tumors and spontaneous leukemia. J Natl Cancer Inst 1971; 47: 1013\u201324.","journal-title":"J Natl Cancer Inst"},{"key":"e_1_2_1_22_2","first-page":"375","article-title":"Effect of Mycobacterium bovis BCG on the growth of transplanted daels' sarcoma in guinea-pigs","volume":"20","author":"Schwartz E","year":"1973","unstructured":"Schwartz E. Effect of Mycobacterium bovis BCG on the growth of transplanted daels' sarcoma in guinea-pigs. Neoplasma 1973; 20: 375\u201386.","journal-title":"Neoplasma"},{"key":"e_1_2_1_23_2","first-page":"803","article-title":"Immunotherapy experiments with a methylcholanthrene-induced guinea pig liposarcoma","volume":"46","author":"Eilber FR","year":"1971","unstructured":"Eilber FR, Holmes EC, Morton DL. Immunotherapy experiments with a methylcholanthrene-induced guinea pig liposarcoma. J Natl Cancer Inst 1971; 46: 803\u20138.","journal-title":"J Natl Cancer Inst"},{"key":"e_1_2_1_24_2","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.1969.101"},{"key":"e_1_2_1_25_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF02137303"},{"key":"e_1_2_1_26_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.170.3963.1217"},{"key":"e_1_2_1_27_2","first-page":"831","article-title":"Suppression of tumor growth at the site of infection with living bacillus Calmette-Gu\u00e9rin","volume":"46","author":"Zbar B","year":"1971","unstructured":"Zbar B, Bernstein ID, Rapp HJ. Suppression of tumor growth at the site of infection with living bacillus Calmette-Gu\u00e9rin. J Natl Cancer Inst 1971; 46: 831\u20139.","journal-title":"J Natl Cancer Inst"},{"key":"e_1_2_1_28_2","first-page":"245","article-title":"Suppression of murine tumor growth by immune reaction to the bacillus Calmette-Gu\u00e9rin strain of Mycobacterium bovis","volume":"48","author":"Bartlett GL","year":"1972","unstructured":"Bartlett GL, Zbar B, Rapp HJ. Suppression of murine tumor growth by immune reaction to the bacillus Calmette-Gu\u00e9rin strain of Mycobacterium bovis. J Natl Cancer Inst 1972; 48: 245\u201357.","journal-title":"J Natl Cancer Inst"},{"key":"e_1_2_1_29_2","first-page":"1709","article-title":"Tumor-specific vaccine containing Mycobacterium bovis and tumor cells: Safety and efficacy","volume":"48","author":"Bartlett GL","year":"1972","unstructured":"Bartlett GL, Zbar B. Tumor-specific vaccine containing Mycobacterium bovis and tumor cells: Safety and efficacy. J Natl Cancer Inst 1972; 48: 1709\u201326.","journal-title":"J Natl Cancer Inst"},{"key":"e_1_2_1_30_2","first-page":"875","article-title":"Influence of BCG infection on growth of 3-methylcholanthrene-induced rat sarcomas","volume":"16","author":"Baldwin RW","year":"1971","unstructured":"Baldwin RW, Pimm MV. Influence of BCG infection on growth of 3-methylcholanthrene-induced rat sarcomas. Rev Eur Etud Clin Biol 1971; 16: 875\u201381.","journal-title":"Rev Eur Etud Clin Biol"},{"key":"e_1_2_1_31_2","doi-asserted-by":"publisher","DOI":"10.7883\/yoken1952.26.71"},{"key":"e_1_2_1_32_2","first-page":"11","article-title":"BCG immunotherapy of rat tumors of defined immunogeneity","volume":"39","author":"Baldwin RW","year":"1973","unstructured":"Baldwin RW, Pimm MV. BCG immunotherapy of rat tumors of defined immunogeneity. Natl Cancer Inst Monogr 1973; 39: 11\u20137.","journal-title":"Natl Cancer Inst Monogr"},{"key":"e_1_2_1_33_2","first-page":"1203","article-title":"La tuberculine et le BCG chez les cancereuz","volume":"65","author":"Holmgren I","year":"1935","unstructured":"Holmgren I. La tuberculine et le BCG chez les cancereuz. Schwiez Med Wochenschr 1935; 65: 1203\u20136.","journal-title":"Schwiez Med Wochenschr"},{"key":"e_1_2_1_34_2","first-page":"619","article-title":"The clinical use of BCG vaccine in stimulating host resistance to cancer. II. Immunochemotherapy in advanced cancer","volume":"41","author":"Villasor RP","year":"1965","unstructured":"Villasor RP. The clinical use of BCG vaccine in stimulating host resistance to cancer. II. Immunochemotherapy in advanced cancer. J Philipp Med Assoc 1965; 41: 619\u201332.","journal-title":"J Philipp Med Assoc"},{"key":"e_1_2_1_35_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(69)92648-8"},{"key":"e_1_2_1_36_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-76-3-405"},{"key":"e_1_2_1_37_2","first-page":"189","article-title":"Treatment of acute lymphoblastic leukemia. Comparison of immunotherapy (BCG), intermittent methotrexate, and no therapy after a five month intensive cytotoxic regimen (Concord Trial)","volume":"4","author":"Leukemia Committee and the Working Party on Leukemia in Childhood.","year":"1971","unstructured":"Leukemia Committee and the Working Party on Leukemia in Childhood. Treatment of acute lymphoblastic leukemia. Comparison of immunotherapy (BCG), intermittent methotrexate, and no therapy after a five month intensive cytotoxic regimen (Concord Trial). Br Med J 1971; 4: 189\u201394.","journal-title":"Br Med J"},{"key":"e_1_2_1_38_2","doi-asserted-by":"publisher","DOI":"10.1159\/000230638"},{"key":"e_1_2_1_39_2","first-page":"526","article-title":"L'etude clique et experimentale des adenitas cervicales chez les enfants vaccines a la naissance par le BCG; lymphodentis becegeica","volume":"3","author":"Kostic-Yoksic SA","year":"1946","unstructured":"Kostic-Yoksic SA. L'etude clique et experimentale des adenitas cervicales chez les enfants vaccines a la naissance par le BCG; lymphodentis becegeica. Arch Fr Pediatr 1946; 3: 526\u201338.","journal-title":"Arch Fr Pediatr"},{"key":"e_1_2_1_40_2","first-page":"15","article-title":"Treatment of bronchial cancer patients with a water-saline extract of BCG","volume":"17","author":"Khadzhiev S","year":"1971","unstructured":"Khadzhiev S, Kavaklieva-Dimitrova Y. Treatment of bronchial cancer patients with a water-saline extract of BCG. Vopr Onkol 1971; 17: 15\u201357.","journal-title":"Vopr Onkol"},{"key":"e_1_2_1_41_2","doi-asserted-by":"publisher","DOI":"10.1136\/thx.29.6.654"},{"key":"e_1_2_1_42_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(76)90213-0"},{"key":"e_1_2_1_43_2","first-page":"99","article-title":"Immunotherapy of human solid tumors and acute leukemia with BCG: Prolongation of disease-free interval and survival","volume":"1","author":"Gutterman JU","year":"1976","unstructured":"Gutterman JU, Mavligit GM, Burgess MA, Immunotherapy of human solid tumors and acute leukemia with BCG: Prolongation of disease-free interval and survival. Cancer Immunol Immunother 1976; 1: 99\u2013107.","journal-title":"Cancer Immunol Immunother"},{"key":"e_1_2_1_44_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM197601292940501"},{"key":"e_1_2_1_45_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-74-4-587"},{"key":"e_1_2_1_46_2","first-page":"162","article-title":"Non-specific and specific immunotherapy in patients with melanoma","volume":"72","author":"Siegler HF","year":"1972","unstructured":"Siegler HF, Shingleton WW, Metzgar RS. Non-specific and specific immunotherapy in patients with melanoma. Surgery 1972; 72: 162\u201374.","journal-title":"Surgery"},{"key":"e_1_2_1_47_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-6632.1976.tb41697.x"},{"key":"e_1_2_1_48_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(76)92093-6"},{"key":"e_1_2_1_49_2","first-page":"3075","article-title":"A phase I study of MER (methanol extraction residue) fraction of BCG as an immunostimulant in patients with advanced cancer","volume":"35","author":"Moertel CG","year":"1975","unstructured":"Moertel CG, Ritts RE, Schutt AJ, Hahn RG. A phase I study of MER (methanol extraction residue) fraction of BCG as an immunostimulant in patients with advanced cancer. Cancer Res 1975; 35: 3075\u201383.","journal-title":"Cancer Res"},{"key":"e_1_2_1_50_2","first-page":"49","article-title":"Adriamycin in the treatment of breast cancer","volume":"4","author":"Gottlieb JA","year":"1975","unstructured":"Gottlieb JA, Blumenschein GR, Gutterman JU. Adriamycin in the treatment of breast cancer. Adriamycin Rev 1975; 4: 49.","journal-title":"Adriamycin Rev"},{"key":"e_1_2_1_51_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF01807895"},{"key":"e_1_2_1_52_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9610(72)90080-3"},{"key":"e_1_2_1_53_2","first-page":"535","article-title":"Chemotherapy versus chemoimmunotherapy of head and neck cancer: Report of a randomized study","volume":"60","author":"Richman SP","year":"1976","unstructured":"Richman SP, Livingston RB, Gutterman JU, Suen JY, Hersh EM. Chemotherapy versus chemoimmunotherapy of head and neck cancer: Report of a randomized study. Cancer Treat Rep 1976; 60: 535\u20139.","journal-title":"Cancer Treat Rep"},{"key":"e_1_2_1_54_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1976.03270200025023"},{"key":"e_1_2_1_55_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19870801)60:3 <502::AID-CNCR2820601512>3.0.CO;2-W"},{"key":"e_1_2_1_56_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-5347(17)42389-5"},{"key":"e_1_2_1_57_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-5347(17)41031-7"},{"key":"e_1_2_1_58_2","first-page":"5","article-title":"Cancer statistics\u20141988","volume":"38","author":"Silverberg E","year":"1988","unstructured":"Silverberg E, Lubera JA. Cancer statistics\u20141988. CA 1988; 38: 5\u201322.","journal-title":"CA"},{"key":"e_1_2_1_59_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(197002)25:2<333::AID-CNCR2820250209>3.0.CO;2-E"},{"key":"e_1_2_1_60_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-5347(17)53725-8"},{"key":"e_1_2_1_61_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-5347(17)55763-8"},{"key":"e_1_2_1_62_2","first-page":"198","article-title":"The natural history of superficial bladder tumors (abstract 785)","volume":"22","author":"MAckenzie N","year":"1980","unstructured":"MAckenzie N, Torti FM, Faysal M. The natural history of superficial bladder tumors (abstract 785). Proc Am Assoc Cancer Res 1980; 22; 198.","journal-title":"Proc Am Assoc Cancer Res"},{"key":"e_1_2_1_63_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-5347(17)58916-8"},{"key":"e_1_2_1_64_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0094-0143(21)00140-3"},{"key":"e_1_2_1_65_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-5347(17)55976-5"},{"key":"e_1_2_1_66_2","first-page":"15","article-title":"Carcinoma in situ of the bladder","volume":"1","author":"Herr HW","year":"1983","unstructured":"Herr HW. Carcinoma in situ of the bladder. Semin Urol 1983; 1: 15\u201322.","journal-title":"Semin Urol"},{"key":"e_1_2_1_67_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0094-0143(21)00766-7"},{"key":"e_1_2_1_68_2","first-page":"198","article-title":"Pathologist's role in bladder cancer","volume":"6","author":"Farrow GM","year":"1979","unstructured":"Farrow GM. Pathologist's role in bladder cancer. Semin Oncol 1979; 6: 198\u2013206.","journal-title":"Semin Oncol"},{"key":"e_1_2_1_69_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19820801)50:3<389::AID-CNCR2820500302>3.0.CO;2-I"},{"key":"e_1_2_1_70_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19870615)59:12<2078::AID-CNCR2820591219>3.0.CO;2-P"},{"key":"e_1_2_1_71_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-5347(17)51695-X"},{"key":"e_1_2_1_72_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-5347(17)52330-7"},{"key":"e_1_2_1_73_2","first-page":"4","article-title":"Diagnosis and management of early stage bladder cancer","author":"Fisher HAG","year":"1986","unstructured":"Fisher HAG. Diagnosis and management of early stage bladder cancer. Curr Concept Oncol 1986;(summer):4\u201311.","journal-title":"Curr Concept Oncol"},{"key":"e_1_2_1_74_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00256518"},{"key":"e_1_2_1_75_2","first-page":"2794","article-title":"Clinical observations on 69 cases of in situ carcinoma of the urinary bladder","volume":"37","author":"Farrow GM","year":"1977","unstructured":"Farrow GM, Utz DC, Rife CC. Clinical observations on 69 cases of in situ carcinoma of the urinary bladder. Cancer Res 1977; 37: 2794\u20138.","journal-title":"Cancer Res"},{"key":"e_1_2_1_76_2","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.1980.45.s7.1879"},{"key":"e_1_2_1_77_2","doi-asserted-by":"publisher","DOI":"10.1159\/000473519"},{"key":"e_1_2_1_78_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-5347(17)55018-1"},{"key":"e_1_2_1_79_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-5347(17)47647-6"},{"key":"e_1_2_1_80_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1980.03310180031028"},{"key":"e_1_2_1_81_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19840301)53:5<1025::AID-CNCR2820530502>3.0.CO;2-D"},{"key":"e_1_2_1_82_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-5347(17)47646-4"},{"key":"e_1_2_1_83_2","doi-asserted-by":"publisher","DOI":"10.1016\/0090-4295(87)90429-8"},{"key":"e_1_2_1_84_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(61)90304-X"},{"key":"e_1_2_1_85_2","doi-asserted-by":"publisher","DOI":"10.1177\/003591576305600838"},{"key":"e_1_2_1_86_2","first-page":"381","article-title":"Treatment of bladder tumors by instillation of thio-tepa, actinomycin D or 5-fluorouracil","volume":"2","author":"Esquivel EL","year":"1965","unstructured":"Esquivel EL, MAckenzie AR, Whitmore WF. Treatment of bladder tumors by instillation of thio-tepa, actinomycin D or 5-fluorouracil. Invest Urol 1965; 2: 381\u20136.","journal-title":"Invest Urol"},{"key":"e_1_2_1_87_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-5347(17)63291-9"},{"key":"e_1_2_1_88_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-5347(17)62408-X"},{"key":"e_1_2_1_89_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1464-410X.1971.tb12024.x"},{"key":"e_1_2_1_90_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1464-410X.1971.tb12090.x"},{"key":"e_1_2_1_91_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-5347(17)56236-9"},{"key":"e_1_2_1_92_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-5347(17)42052-0"},{"key":"e_1_2_1_93_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1464-410X.1976.tb02742.x"},{"key":"e_1_2_1_94_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-5347(17)51400-7"},{"key":"e_1_2_1_95_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-5347(17)66989-1"},{"key":"e_1_2_1_96_2","doi-asserted-by":"publisher","DOI":"10.1016\/0090-4295(80)90322-2"},{"key":"e_1_2_1_97_2","first-page":"225","article-title":"Phase I\u2014II study of mitomycin C topical therapy for low-grade, low-stage transitional cell carcinoma of the bladder: An interim report","volume":"64","author":"Defuria MD","year":"1980","unstructured":"Defuria MD, Bracken RB, Johnson DE, Phase I\u2014II study of mitomycin C topical therapy for low-grade, low-stage transitional cell carcinoma of the bladder: An interim report. Cancer Treat Rep 1980; 64: 225\u201330.","journal-title":"Cancer Treat Rep"},{"key":"e_1_2_1_98_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-5347(17)55149-6"},{"key":"e_1_2_1_99_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-5347(17)58737-6"},{"key":"e_1_2_1_100_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-5347(17)46969-2"},{"key":"e_1_2_1_101_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-5347(17)46976-X"},{"key":"e_1_2_1_102_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-5347(17)45604-7"},{"key":"e_1_2_1_103_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-5347(17)53283-8"},{"key":"e_1_2_1_104_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-5347(17)52736-6"},{"key":"e_1_2_1_105_2","first-page":"551","article-title":"Recurrent bladder papillomata treated with bacillus Calmette-Gu\u00e9rin: A preliminary report (phase 1)","volume":"62","author":"Douville Y","year":"1978","unstructured":"Douville Y, Pelouze G, Roy R, Charrois R, Recurrent bladder papillomata treated with bacillus Calmette-Gu\u00e9rin: A preliminary report (phase 1). Cancer Treat Rep 1978; 62: 551\u20132.","journal-title":"Cancer Treat Rep"},{"key":"e_1_2_1_106_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-5347(17)55150-2"},{"key":"e_1_2_1_107_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00199531"},{"key":"e_1_2_1_108_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-5347(17)46972-2"},{"key":"e_1_2_1_109_2","first-page":"359","article-title":"Treatment of superficial bladder cancer with intravesical BCG (abstract C-160)","volume":"21","author":"Camacho F","year":"1980","unstructured":"Camacho F, Pinsky C, Kerr D, Whitmore W, Oettgen H. Treatment of superficial bladder cancer with intravesical BCG (abstract C-160). Proc Am Assoc Cancer Res Am Soc Clin Oncol 1980; 21: 359.","journal-title":"Proc Am Assoc Cancer Res Am Soc Clin Oncol"},{"key":"e_1_2_1_110_2","doi-asserted-by":"publisher","DOI":"10.1159\/000463764"},{"key":"e_1_2_1_111_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1464-410X.1977.tb04549.x"},{"key":"e_1_2_1_112_2","first-page":"184A","article-title":"BCG vs adriamycin in the treatment of transitional cell carcinoma in situ: A Southwest Oncology Group study (abstract 283)","volume":"133","author":"Stanisic TH","year":"1985","unstructured":"Stanisic TH, Grossman HB, Sullivan JW. BCG vs adriamycin in the treatment of transitional cell carcinoma in situ: A Southwest Oncology Group study (abstract 283). J Urol 1985; 133: 184A","journal-title":"J Urol"},{"key":"e_1_2_1_113_2","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-642-81332-0_51"},{"key":"e_1_2_1_114_2","first-page":"1109","article-title":"Phase II trial of bleomycin in superficial bladder cancer","volume":"62","author":"Gad-El-Mawla NM","year":"1978","unstructured":"Gad-El-Mawla NM, Ziegler JL. Phase II trial of bleomycin in superficial bladder cancer. Cancer Treat Rep 1978; 62: 1109\u201310.","journal-title":"Cancer Treat Rep"},{"key":"e_1_2_1_115_2","first-page":"1579","article-title":"Treatment of genitourinary tumors with cis-dichlorodiam-mineplatinum (II): Experience in 250 patients","volume":"63","author":"Merrin CE","year":"1979","unstructured":"Merrin CE. Treatment of genitourinary tumors with cis-dichlorodiam-mineplatinum (II): Experience in 250 patients. Cancer Treat Rep 1979; 63: 1579\u201384.","journal-title":"Cancer Treat Rep"},{"key":"e_1_2_1_116_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19820901)50:5<863::AID-CNCR2820500509>3.0.CO;2-Q"},{"key":"e_1_2_1_117_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-5347(17)49449-3"},{"key":"e_1_2_1_118_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-5347(17)43644-5"},{"key":"e_1_2_1_119_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-5347(17)40575-1"},{"key":"e_1_2_1_120_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF02090950"},{"key":"e_1_2_1_121_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.124.6.1039"},{"key":"e_1_2_1_122_2","first-page":"157","article-title":"Nonspecific stimulation and modulation of the immune response and of states of resistance by the methanol-extraction residue fraction of tubercle bacilli","volume":"35","author":"Weiss DW","year":"1972","unstructured":"Weiss DW. Nonspecific stimulation and modulation of the immune response and of states of resistance by the methanol-extraction residue fraction of tubercle bacilli. Natl Cancer Inst Monogr 1972; 35: 157\u201371.","journal-title":"Natl Cancer Inst Monogr"},{"key":"e_1_2_1_123_2","first-page":"871","article-title":"Action du BCG sur l'activite catalasique hepatique chez la souris: Relations avec le systeme reticuloendothelial et la resistance a la leucose greffee AKR","volume":"13","author":"Lamensans A","year":"1968","unstructured":"Lamensans A, Mollier MF, Laurent M. Action du BCG sur l'activite catalasique hepatique chez la souris: Relations avec le systeme reticuloendothelial et la resistance a la leucose greffee AKR. Rev Eur Etud Clin Biol 1968; 13: 871\u20136.","journal-title":"Rev Eur Etud Clin Biol"},{"key":"e_1_2_1_124_2","first-page":"912","article-title":"Immunotherapie active non-specifique par le BCG de la laucemie virale E male G2 chez des receveurs isogentiques","volume":"12","author":"Amiel JL","year":"1967","unstructured":"Amiel JL. Immunotherapie active non-specifique par le BCG de la laucemie virale E male G2 chez des receveurs isogentiques. Rev Eur Etud Clin Biol 1967; 12: 912\u20134.","journal-title":"Rev Eur Etud Clin Biol"},{"key":"e_1_2_1_125_2","first-page":"585","article-title":"Essais de traitements de la leucemia E male G2 associant chemotherapic et immunotherapies actives non-specifique et specifique","volume":"14","author":"Amiel JL","year":"1969","unstructured":"Amiel JL, Beradet M. Essais de traitements de la leucemia E male G2 associant chemotherapic et immunotherapies actives non-specifique et specifique. Rev Eur Etud Clin Biol 1969; 14: 585\u20138.","journal-title":"Rev Eur Etud Clin Biol"},{"key":"e_1_2_1_126_2","doi-asserted-by":"publisher","DOI":"10.3181\/00379727-111-27908"},{"key":"e_1_2_1_127_2","first-page":"1281","article-title":"The role of the reticuloendothelial system in the host reaction to neoplasma","volume":"21","author":"Old LJ","year":"1961","unstructured":"Old LJ, Benacerraf B, Clarke DA, The role of the reticuloendothelial system in the host reaction to neoplasma. Cancer Res 1961; 21: 1281\u2013300.","journal-title":"Cancer Res"},{"key":"e_1_2_1_128_2","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/51.1.241"},{"key":"e_1_2_1_129_2","first-page":"433","article-title":"Suppression of tumor growth and induction of specific tumor immunity by intradermal inoculation of a mixture of living tumor cells and live Mycobacterium bovis in mice","volume":"62","author":"Tanaka T","year":"1971","unstructured":"Tanaka T, Tokunaga T. Suppression of tumor growth and induction of specific tumor immunity by intradermal inoculation of a mixture of living tumor cells and live Mycobacterium bovis in mice. Gunn 1971; 62: 433\u20134.","journal-title":"Gunn"},{"key":"e_1_2_1_130_2","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/51.5.1627"},{"key":"e_1_2_1_131_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.172.3980.271"},{"key":"e_1_2_1_132_2","first-page":"119","article-title":"Immunotherapy of cancer: Regression of intradermal tumors and prevention of growth of lymph node metastases after intralesional injection of living Mycobacterium bovis","volume":"49","author":"Zbar B","year":"1972","unstructured":"Zbar B, Bernstein ID, Bartlett GL, Immunotherapy of cancer: Regression of intradermal tumors and prevention of growth of lymph node metastases after intralesional injection of living Mycobacterium bovis. J Natl Cancer Inst 1972; 49: 119\u201330.","journal-title":"J Natl Cancer Inst"},{"key":"e_1_2_1_133_2","first-page":"366","article-title":"A guinea pig model for tumor immunology: A summary","volume":"9","author":"Rapp HJ","year":"1973","unstructured":"Rapp HJ. A guinea pig model for tumor immunology: A summary. Inst Med Sci 1973; 9: 366\u201374.","journal-title":"Inst Med Sci"},{"key":"e_1_2_1_134_2","first-page":"3","article-title":"An experimental model for immunotherapy of cancer","volume":"39","author":"Zbar B","year":"1973","unstructured":"Zbar B, Ribi E, Rapp HJ. An experimental model for immunotherapy of cancer. Natl Cancer Inst Monogr 1973; 39: 3\u20136.","journal-title":"Natl Cancer Inst Monogr"},{"key":"e_1_2_1_135_2","doi-asserted-by":"publisher","DOI":"10.1016\/0090-4295(74)90010-7"},{"key":"e_1_2_1_136_2","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/51.5.1677"},{"key":"e_1_2_1_137_2","first-page":"423","article-title":"The effects of BCG on dog bladders","volume":"12","author":"Bloomberg SD","year":"1975","unstructured":"Bloomberg SD, Brosman SA, Hausman MD, The effects of BCG on dog bladders. Invest Urol 1975; 12: 423\u20137.","journal-title":"Invest Urol"},{"key":"e_1_2_1_138_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-5347(17)55282-9"},{"key":"e_1_2_1_139_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1464-410X.1987.tb05039.x"},{"key":"e_1_2_1_140_2","first-page":"164","article-title":"The granulomatous inflammatory response: A review","volume":"84","author":"Adams DO","year":"1976","unstructured":"Adams DO. The granulomatous inflammatory response: A review. Am J Pathol 1976; 84: 164\u201391.","journal-title":"Am J Pathol"},{"key":"e_1_2_1_141_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19830401)51:7<1323::AID-CNCR2820510724>3.0.CO;2-2"},{"key":"e_1_2_1_142_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19810701)48:1<82::AID-CNCR2820480117>3.0.CO;2-Z"},{"key":"e_1_2_1_143_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-5347(17)42723-6"},{"key":"e_1_2_1_144_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.72.9.3666"},{"key":"e_1_2_1_145_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.80.20.6341"},{"key":"e_1_2_1_146_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.80.17.5397"},{"key":"e_1_2_1_147_2","unstructured":"Catalona WJ Shapiro A Ratliff TL Oakley D. Interferon induction during intravesical bacillus Calmette-Gu\u00e9rin (BCG) therapy. Paper presented at the 19th International Congress of the Societe Internationale d'urologie San Francisco September 1982."},{"key":"e_1_2_1_148_2","unstructured":"Shapiro A Ratliff TL Oakley DM Catalona WJ. Reduction of bladder tumor growth in BCG treated mice: its correlation to natural killer cell (NK) activity and interferon levels (abstract 55). Paper presented at the 20th annual meeting of the American Urological Association May 1982."},{"key":"e_1_2_1_149_2","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.2910110304"},{"key":"e_1_2_1_150_2","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/53.5.1313"},{"key":"e_1_2_1_151_2","first-page":"133","volume-title":"Pathobiology annual","author":"Hersh EM","year":"1975","unstructured":"Hersh EM, Gutterman JU, Mavligit GM. Cancer and host defense mechanisms. In: Ioachin HL, ed. Pathobiology annual. New York: Appleton-Century-Crofts, 1975: 133."},{"key":"e_1_2_1_152_2","doi-asserted-by":"publisher","DOI":"10.1097\/00000658-197010000-00018"},{"key":"e_1_2_1_153_2","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.1968.47"},{"key":"e_1_2_1_154_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0025-7125(16)31902-2"},{"key":"e_1_2_1_155_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.2.5312.1086"},{"key":"e_1_2_1_156_2","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/51.5.1655"},{"key":"e_1_2_1_157_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1976.03260320052031"},{"key":"e_1_2_1_158_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.120.2.563"},{"key":"e_1_2_1_159_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19800801)46:3<480::AID-CNCR2820460311>3.0.CO;2-C"},{"key":"e_1_2_1_160_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(73)90526-6"},{"key":"e_1_2_1_161_2","unstructured":"Mardiney MR. Screening of systemic adjuvants of immunity (experimental and clinical). Paper presented at 1972 Paris cancer week Paris June 19\u201323 1972."},{"key":"e_1_2_1_162_2","unstructured":"Powles R. Immunotherapy in acute leukemia. Paper presented at 1972 Paris cancer week Paris June 19\u201323 1972."},{"key":"e_1_2_1_163_2","unstructured":"Weiner R. A comparison of BCG strains around the world in oncology in experimental animals (NCI monograph no. 39). Presented at the conference on the use of BCG in therapy of cancer Washingon DC October 5\u20136 1972."},{"key":"e_1_2_1_164_2","first-page":"699","article-title":"Differential characteristics in vitro and in vivo of several substrains of BCG iv. Immunizing effectiveness","volume":"74","author":"Dubos RJ","year":"1956","unstructured":"Dubos RJ, Pierce CH. Differential characteristics in vitro and in vivo of several substrains of BCG iv. Immunizing effectiveness. Am Rev Tuberc 1956; 74: 699\u2013717.","journal-title":"Am Rev Tuberc"},{"key":"e_1_2_1_165_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1464-410X.1987.tb04876.x"},{"key":"e_1_2_1_166_2","first-page":"137","article-title":"Comparaison de quatre seed-lots par le test de Jensen","volume":"17","author":"Rodopska S","year":"1971","unstructured":"Rodopska S. Comparaison de quatre seed-lots par le test de Jensen. Symp Ser Immunobiol Stand 1971; 17: 137\u20138.","journal-title":"Symp Ser Immunobiol Stand"},{"key":"e_1_2_1_167_2","doi-asserted-by":"publisher","DOI":"10.1016\/0041-3879(72)90024-4"},{"key":"e_1_2_1_168_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-5347(17)39441-7"},{"key":"e_1_2_1_169_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-5347(17)45606-0"},{"key":"e_1_2_1_170_2","volume-title":"Non-specific immunotherapy with BCG-RIVM in superficial bladder cancer [thesis]","author":"Van Der Meijden APM","year":"1986","unstructured":"Van Der Meijden APM. Non-specific immunotherapy with BCG-RIVM in superficial bladder cancer [thesis]. Nijmegen, The Netherlands: University of Nijmegen Department of Urology, 1986."},{"key":"e_1_2_1_171_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-5347(17)45639-4"},{"key":"e_1_2_1_172_2","first-page":"186","article-title":"Nephrogenic adenoma of urinary bladder due to intravesical BCG therapy (abstract)","volume":"135","author":"Oates R","year":"1986","unstructured":"Oates R, Siroky MB. Nephrogenic adenoma of urinary bladder due to intravesical BCG therapy (abstract). J Urol 1986; 135: 186.","journal-title":"J Urol"},{"key":"e_1_2_1_173_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-5347(17)41803-9"},{"key":"e_1_2_1_174_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0025-7125(16)31894-6"},{"key":"e_1_2_1_175_2","unstructured":"Lamm DL. Complications of intravesical BCG immunotherapy. Presentations of the Internatioanl Workshop on BCG in Superficial Bladder Cancer Kerkrade The Netherlands September 7\u20138 1988."},{"key":"e_1_2_1_176_2","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.2910140117"},{"key":"e_1_2_1_177_2","doi-asserted-by":"publisher","DOI":"10.1038\/2281210a0"},{"key":"e_1_2_1_178_2","doi-asserted-by":"publisher","DOI":"10.1002\/jso.2930150307"},{"key":"e_1_2_1_179_2","first-page":"3262","article-title":"Tumor regression and enhancement resulting from immunotherapy with bacillus Calmette-Gu\u00e9rin and neuraminidase","volume":"34","author":"Sparks FC","year":"1974","unstructured":"Sparks FC, Breeding JH. Tumor regression and enhancement resulting from immunotherapy with bacillus Calmette-Gu\u00e9rin and neuraminidase. Cancer Res 1974; 34: 3262\u20139.","journal-title":"Cancer Res"},{"key":"e_1_2_1_180_2","doi-asserted-by":"publisher","DOI":"10.1016\/0090-4295(88)90208-7"},{"key":"e_1_2_1_181_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-5347(17)54175-0"},{"key":"e_1_2_1_182_2","doi-asserted-by":"publisher","DOI":"10.1159\/000472047"},{"key":"e_1_2_1_183_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1987.5.3.441"},{"key":"e_1_2_1_184_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-5347(17)42722-4"}],"container-title":["DICP"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/106002809102501215","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/106002809102501215","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T11:04:54Z","timestamp":1777374294000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/106002809102501215"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1991,12]]},"references-count":183,"journal-issue":{"issue":"12","published-print":{"date-parts":[[1991,12]]}},"alternative-id":["10.1177\/106002809102501215"],"URL":"https:\/\/doi.org\/10.1177\/106002809102501215","relation":{},"ISSN":["1042-9611"],"issn-type":[{"value":"1042-9611","type":"print"}],"subject":[],"published":{"date-parts":[[1991,12]]}}}